Biblio
“Disruptive chemicals, senescence and immortality”, Carcinogenesis, vol. 36, pp. S19–S37, 2015.
, “Disruptive chemicals, senescence and immortality”, Carcinogenesis, vol. 36, pp. S19–S37, 2015.
, “Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death”, Carcinogenesis, vol. 36, pp. S89–S110, 2015.
, “Divergent Ah receptor ligand selectivity during hominin evolution.”, Mol Biol Evol, 2016.
, “Drug repurposing in chemical genomics: can we learn from the past to improve the future?”, Current topics in medicinal chemistry, vol. 12, pp. 1883–1888, 2012.
, “Editorial: computational chemogenomics in drug design and discovery.”, Current topics in medicinal chemistry, vol. 12, p. 1867, 2012.
, “Environmental immune disruptors, inflammation and cancer risk”, Carcinogenesis, vol. 36, pp. S232–S253, 2015.
, “Environmental immune disruptors, inflammation and carcinogenesis: A state of the science and new horizons”, Toxicology Letters, vol. 280, pp. S9 - S10, 2017.
, “Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro”, Toxicological sciences, p. kfq379, 2010.
, “Evidence of selective activation of aryl hydrocarbon receptor nongenomic calcium signaling by pyrene”, Biochemical Pharmacology, vol. 158, pp. 1 - 12, 2018.
, “Factors governing 310-helix vs $\alpha$-helix formation in peptides: Percentage of C$\alpha$-tetrasubstituted $\alpha$-amino acid residues and sequence dependence”, Biopolymers, vol. 64, pp. 236–245, 2002.
, , “HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates”, Epigenetics, vol. 8, pp. 612–623, 2013.
, “HDAC8 and STAT3 repress BMF gene activity in colon cancer cells”, Cell death & disease, vol. 5, p. e1476, 2014.
, “Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.”, Curr Top Med Chem, vol. 16, no. 7, pp. 714-31, 2016.
, “Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes $\alpha$4$\beta$2 and $\alpha$7”, Journal of molecular modeling, vol. 14, pp. 891–899, 2008.
, “Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism”, Journal of Pharmacology and Experimental Therapeutics, vol. 338, pp. 318–327, 2011.
, “Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells”, Biology (Basel), vol. 6, no. 4, 2017.
, “Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells.”, Biology (Basel), vol. 6, no. 4, 2017.
, “The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis”, Carcinogenesis, vol. 36, pp. S128–S159, 2015.
, “Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity”, Journal of hepatology, 2015.
, “Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction”, Nature Communications, vol. 6, p. 10166, 2015.
, “ -Keto Acid Metabolites of Naturally Occurring Organoselenium Compounds as Inhibitors of Histone Deacetylase in Human Prostate Cancer Cells”, Cancer Prevention Research, vol. 2, no. 7, pp. 683 - 693, 2009.
, “Ligand selectivity for the acetylcholine binding site of the rat $\alpha$4$\beta$2 and $\alpha$3$\beta$4 nicotinic subtypes investigated by molecular docking”, Journal of medicinal chemistry, vol. 48, pp. 5123–5130, 2005.
, “Ligand-specific transcriptional mechanisms underlie aryl hydrocarbon receptor-mediated developmental toxicity of oxygenated PAHs”, Toxicological Sciences, p. kfv139, 2015.
,